229 related articles for article (PubMed ID: 29138858)
1. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.
Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S
Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer.
Tang Y; Wu B; Huang S; Peng X; Li X; Huang X; Zhou W; Xie P; He P
Oncol Rep; 2019 Jan; 41(1):57-66. PubMed ID: 30365141
[TBL] [Abstract][Full Text] [Related]
3. The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.
Dai Y; Ren D; Yang Q; Cui Y; Guo W; Lai Y; Du H; Lin C; Li J; Song L; Peng X
Br J Cancer; 2017 Aug; 117(5):685-694. PubMed ID: 28697177
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling.
Huang S; Wa Q; Pan J; Peng X; Ren D; Li Q; Dai Y; Yang Q; Huang Y; Zhang X; Zhou W; Yuan D; Cao J; Li Y; He P; Tang Y
Cell Death Dis; 2018 Jul; 9(7):779. PubMed ID: 30006541
[TBL] [Abstract][Full Text] [Related]
6. miR‑19a‑3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion.
Feng S; Zhu X; Fan B; Xie D; Li T; Zhang X
Mol Med Rep; 2016 May; 13(5):4030-8. PubMed ID: 27035427
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
Sun B; Fan Y; Yang A; Liang L; Cao J
J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
[TBL] [Abstract][Full Text] [Related]
8. SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis.
Lang C; Dai Y; Wu Z; Yang Q; He S; Zhang X; Guo W; Lai Y; Du H; Wang H; Ren D; Peng X
Mol Oncol; 2020 Apr; 14(4):808-828. PubMed ID: 31925912
[TBL] [Abstract][Full Text] [Related]
9. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway.
Liu X; Chen L; Fan Y; Hong Y; Yang X; Li Y; Lu J; Lv J; Pan X; Qu F; Cui X; Gao Y; Xu D
Cell Death Dis; 2019 Jul; 10(7):517. PubMed ID: 31273201
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway.
Siu MK; Tsai YC; Chang YS; Yin JJ; Suau F; Chen WY; Liu YN
Oncogene; 2015 Sep; 34(36):4767-76. PubMed ID: 25531317
[TBL] [Abstract][Full Text] [Related]
11. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
[TBL] [Abstract][Full Text] [Related]
12. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
13. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling.
Li Q; Ye L; Zhang X; Wang M; Lin C; Huang S; Guo W; Lai Y; Du H; Li J; Song L; Peng X
Cancer Lett; 2017 Aug; 402():166-176. PubMed ID: 28602974
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase.
Fu Q; Liu X; Liu Y; Yang J; Lv G; Dong S
Int J Mol Med; 2015 Nov; 36(5):1417-25. PubMed ID: 26647850
[TBL] [Abstract][Full Text] [Related]
15. TGFβ Induces a Pro-Bone Metastasis Program in Prostate Cancer.
Cancer Discov; 2015 Jul; 5(7):OF23. PubMed ID: 26022606
[TBL] [Abstract][Full Text] [Related]
16. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI.
Zhu M; Chen Q; Liu X; Sun Q; Zhao X; Deng R; Wang Y; Huang J; Xu M; Yan J; Yu J
FEBS J; 2014 Aug; 281(16):3766-75. PubMed ID: 24988946
[TBL] [Abstract][Full Text] [Related]
17. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
[TBL] [Abstract][Full Text] [Related]
19. Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis.
Zhu Z; Wen Y; Xuan C; Chen Q; Xiang Q; Wang J; Liu Y; Luo L; Zhao S; Deng Y; Zhao Z
FEBS Open Bio; 2020 Apr; 10(4):674-688. PubMed ID: 32027093
[TBL] [Abstract][Full Text] [Related]
20. SMAD4 suppresses AURKA-induced metastatic phenotypes via degradation of AURKA in a TGFβ-independent manner.
Jia L; Lee HS; Wu CF; Kundu J; Park SG; Kim RN; Wang LH; Erkin ÖC; Choi JS; Chae SW; Yang HB; Choi YL; Shin YK
Mol Cancer Res; 2014 Dec; 12(12):1779-95. PubMed ID: 25061104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]